Bioactive peptides from Torreya grandis nuts reduced body weight, cholesterol, and tissue lipid deposits while improving gut microbiota in high-fat diet mice, acting through the PPAR-α lipid regulation pathway.
Multi-target metabolic improvementNut-derived peptides simultaneously reduced body weight, cholesterol, tissue lipid deposits, inflammation, and oxidative stress while improving gut microbiota
What the researchers found
Peptides derived from Torreya grandis nuts improved multiple metabolic markers in mice fed a high-fat diet. The supplementation reduced body weight, total cholesterol, triglycerides, and LDL while increasing HDL. Lipid droplet accumulation in the liver, muscles, and blood vessels was markedly reduced in the high-peptide group.
The peptides also favorably shifted gut microbiota composition, increasing beneficial Akkermansia and Parabacteroides while decreasing Firmicutes, which boosted short-chain fatty acid production. Proteome analysis identified a vicilin-like antimicrobial peptide, and transcriptome analysis showed lipid regulation via the PPAR-α pathway. Molecular docking identified 4 potential lipid II inhibitory peptides.
Why it matters
With obesity and metabolic syndrome reaching epidemic levels, food-derived bioactive peptides represent a potential dietary intervention strategy. This study provides a comprehensive multi-omics characterization of how nut-derived peptides affect lipid metabolism, gut microbiota, and gene expression — connecting peptide supplementation to multiple beneficial pathways simultaneously.
How the study worked
Mice were fed a high-fat diet with or without Torreya grandis nut peptide supplementation. Researchers used proteome analysis to identify bioactive peptides, 16S rRNA sequencing to characterize gut microbiota changes, transcriptome analysis to identify lipid regulation pathways, and molecular docking to identify potential lipid II inhibitory peptides. Blood lipids, inflammation markers, oxidative stress, and tissue lipid droplets were measured.
Who was studied
Mice fed a high-fat diet
What this study cannot tell us
This is a mouse study and results may not translate directly to humans. The specific peptide doses and treatment duration are not detailed in the abstract. The identified lipid II inhibitory peptides are based on molecular docking predictions and need experimental validation. The gut microbiota findings in mice may differ from human responses.
How to read the evidence
This is a preliminary-grade animal study. While the multi-omics approach is thorough and the metabolic improvements are broad, all data come from mice and the specific peptides' mechanisms are partly based on computational predictions rather than experimental confirmation.
When this study was published
Published in 2025, this is very recent research applying modern multi-omics techniques to characterize nut-derived bioactive peptides.
The bigger picture
Food-derived bioactive peptides are increasingly recognized as a bridge between nutrition and pharmacology. This study adds Torreya grandis to the growing list of plant sources yielding peptides with measurable metabolic benefits, and the multi-omics approach (proteomics, metagenomics, transcriptomics) sets a new standard for characterizing how food peptides work at the molecular level.
Questions still open
- Can the four identified lipid II inhibitory peptides be synthesized and tested individually to confirm which are most responsible for the metabolic benefits?
- Would Torreya grandis nut peptides have similar lipid-lowering and microbiome effects in humans with metabolic syndrome?
- How do the bioactive peptides survive digestion to reach the gut and exert their effects on microbiota composition?
Common questions
What is Torreya grandis and are its nuts commonly eaten?
How do nut peptides improve gut bacteria?
Read the original research
Torreya grandis nut peptides regulate lipid-II inhibitors in high-fat diet-fed mice.
Food chemistry. Molecular sciences, 11, 100273
Citation
Durrani, Rabia; Yutian, Sun; Bowen, Hou; Ullah, Hammad; Durand, Erwann; Meiyun, Yang; Yiyang, Long; Delavault, André; Yasir, Muhammad; Weiwei, Huan; Fei, Gao; Lili, Song. (2025). Torreya grandis nut peptides regulate lipid-II inhibitors in high-fat diet-fed mice.. Food chemistry. Molecular sciences, 11, 100273. https://doi.org/10.1016/j.fochms.2025.100273